Clinical Trial Update: Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine. [Phase 1]

View source ↗

Summary

Open-label Phase 1 study evaluating drug interaction between eslicarbazepine acetate and lamotrigine in epilepsy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)
• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED